New User? Sign Up | Sign In

Insider Trading - Crinetics Pharmaceuticals Inc. (CRNX)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

CRNX Insider Trading Transactions for Crinetics Pharmaceuticals Inc.
Goto page 0, 1, Next

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2019-03-18
Sale
2019-03-20
4:48 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
154,839 $24.25 $3,754,954 104,489
(Indirect)
View
2019-03-20
Sale
2019-03-25
06:04 am
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
417,000 $22.25 $9,278,250 210,373
(Indirect)
View
2019-06-21
Sale
2019-06-25
7:03 pm
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
Former 10% holder
250,000 $22.2 $5,550,000 94,489
(Indirect)
View
2019-12-16
Sale
2019-12-18
6:32 pm
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
3,500 $22.5 $78,750 12,536
(Direct)
View
2020-01-29
Sale
2020-01-31
8:00 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
26,920 $22.07 $594,164 189,335
(Indirect)
View
2020-02-04
Sale
2020-02-06
7:22 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
13,460 $22.8 $306,888 178,816
(Indirect)
View
2020-02-07
Sale
2020-02-11
8:00 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
13,460 $21.66 $291,587 168,298
(Indirect)
View
2020-03-09
Sale
2020-03-11
5:12 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
Vivo Opportunity LLC
Vivo Opportunity Fund L.P.
10% Owner
528 $19.5 $10,296 168,165
(Indirect)
View
2020-04-03
Sale
2020-04-07
7:27 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
306,115 $13.81 $4,226,833 338,738
(Indirect)
View
2020-04-15
Sale
2020-04-17
6:38 pm
Crinetics Pharmaceuticals Inc. CRNX Vivo Capital VIII LLC
Vivo Capital Fund VIII L.P.
Vivo Capital Surplus Fund VIII L.P.
10% Owner
330,598 $15.45 $5,106,752 298,625
(Indirect)
View
2020-04-17
Purchase
2020-04-20
08:30 am
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
1,071,428 $14 $14,999,992 3,659,381
(Indirect)
View
2020-07-15
Sale
2020-07-17
5:05 pm
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
35,000 $14.88 $520,830 890,805
(Indirect)
View
2020-12-02
Purchase
2020-12-04
4:59 pm
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
5,000 $13 $65,000 4,000
(Indirect
Direct)
View
2021-04-08
Purchase
2021-04-09
09:00 am
Crinetics Pharmaceuticals Inc. CRNX PERCEPTIVE ADVISORS LLC
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD
EDELMAN JOSEPH
10% Owner
304,136 $16.44 $4,999,996 3,963,517
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
445,470 $0 2,524,456
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
13,387 $0 75,949
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
14,828 $0 84,161
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
33,903 $0 192,122
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
9,473 $0 9,473
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
9,473 $0 0
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
678 $0 678
(Indirect)
View
2019-02-04
Other
2019-02-06
5:35 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Versant Venture Capital V L.P.
Versant Affiliates Fund V L.P.
Versant Ophthalmic Affiliates I L.P.
Versant Venture Capital V (Canada) LP
Versant Ventures V LLC
Versant Ventures V (Canada) L.P.
10% Owner
678 $0 0
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
451,200 $0 2,656,442
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
18,800 $0 110,683
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,700 $0 4,700
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
4,700 $0 0
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
940 $0 940
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
940 $0 940
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
353 $0 353
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
587 $0 940
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 1,723
(Indirect)
View
2019-02-20
Other
2019-02-22
8:06 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX 5AM Ventures IV L.P.
5AM Co-Investors IV L.P.
5AM Partners IV LLC
ROCKLAGE SCOTT M
DIEKMAN JOHN D
Schwab Andrew J.
10% Owner
783 $0 1,723
(Indirect)
View
2019-03-08
Option Award
2019-03-12
6:42 pm
N/A
2029-03-07
Crinetics Pharmaceuticals Inc. CRNX Krasner Alan Seth
Chief Medical Officer
56,250 $0 56,250
(Direct)
View
2019-03-08
Option Award
2019-03-12
6:43 pm
N/A
2029-03-07
Crinetics Pharmaceuticals Inc. CRNX Wilson Marc
CFO
56,250 $0 56,250
(Direct)
View
2019-03-08
Option Award
2019-03-12
6:44 pm
N/A
2029-03-07
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
176,250 $0 176,250
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:07 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
12,500 $0 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:08 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Kaldor Stephen W
Director
12,500 $0 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:09 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
12,500 $0 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:10 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Nielsen Jack
Director
12,500 $0 12,500
(Direct)
View
2019-06-21
Option Award
2019-06-25
4:10 pm
N/A
2029-06-20
Crinetics Pharmaceuticals Inc. CRNX Nichols Weston
Director
12,500 $0 12,500
(Direct)
View
2019-07-15
Option Award
2019-07-16
7:56 pm
N/A
2029-07-14
Crinetics Pharmaceuticals Inc. CRNX Okey Stephanie
Director
25,000 $0 25,000
(Direct)
View
2019-08-05
Gift
2019-08-07
7:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
1,215,805 $0 0
(Direct)
View
2019-08-05
Gift
2019-08-07
7:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
1,215,805 $0 1,215,805
(Indirect)
View
2019-08-05
Exercise
2019-08-07
7:31 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
10,000 $1.91 1,225,805
(Indirect)
View
2019-08-05
Exercise
2019-08-07
7:31 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
10,000 $0 172,370
(Direct)
View
2019-12-16
Exercise
2019-12-18
6:32 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
3,500 $1.91 16,036
(Direct)
View
2019-12-16
Exercise
2019-12-18
6:32 pm
N/A
2028-03-16
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
3,500 $0 42,092
(Direct)
View
2020-02-24
Option Award
2020-02-26
4:12 pm
N/A
2030-02-23
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
200,000 $0 200,000
(Direct)
View
2020-02-24
Option Award
2020-02-26
4:15 pm
N/A
2030-02-23
Crinetics Pharmaceuticals Inc. CRNX Wilson Marc
CFO
70,000 $0 70,000
(Direct)
View
2020-02-24
Option Award
2020-02-26
4:18 pm
N/A
2030-02-23
Crinetics Pharmaceuticals Inc. CRNX Krasner Alan Seth
Chief Medical Officer
45,000 $0 45,000
(Direct)
View
2020-04-28
Exercise
2020-04-29
5:01 pm
N/A
N/A
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
25,329 $0.73 99,846
(Direct)
View
2020-04-28
Exercise
2020-04-29
5:01 pm
N/A
2025-12-10
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
25,329 $0 12,500
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:17 pm
N/A
2030-06-18
Crinetics Pharmaceuticals Inc. CRNX WIERENGA WENDALL
Director
12,500 $0 12,500
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:19 pm
N/A
2020-06-18
Crinetics Pharmaceuticals Inc. CRNX Okey Stephanie
Director
12,500 $0 12,500
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:20 pm
N/A
2030-06-18
Crinetics Pharmaceuticals Inc. CRNX Nichols Weston
Director
12,500 $0 12,500
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:22 pm
N/A
2030-06-18
Crinetics Pharmaceuticals Inc. CRNX Kaldor Stephen W
Director
12,500 $0 12,500
(Direct)
View
2020-06-19
Option Award
2020-06-22
4:24 pm
N/A
2030-06-18
Crinetics Pharmaceuticals Inc. CRNX Fust Matthew K
Director
12,500 $0 12,500
(Direct)
View
2020-09-01
Option Award
2020-09-03
5:58 pm
N/A
2030-08-31
Crinetics Pharmaceuticals Inc. CRNX Bedrosian Camille L
Director
25,000 $0 25,000
(Direct)
View
2021-02-26
Option Award
2021-03-02
5:21 pm
N/A
2031-02-25
Crinetics Pharmaceuticals Inc. CRNX Struthers Richard Scott
CEO
294,000 $0 294,000
(Direct)
View
2021-02-26
Option Award
2021-03-02
5:23 pm
N/A
2031-02-25
Crinetics Pharmaceuticals Inc. CRNX Wilson Marc
CFO
114,000 $0 114,000
(Direct)
View
2021-02-26
Option Award
2021-03-02
5:25 pm
N/A
2031-02-25
Crinetics Pharmaceuticals Inc. CRNX Madan Ajay
Chief Development Officer
131,000 $0 131,000
(Direct)
View
2021-02-26
Option Award
2021-03-02
5:27 pm
N/A
2031-02-25
Crinetics Pharmaceuticals Inc. CRNX Krasner Alan Seth
Chief Medical Officer
125,000 $0 125,000
(Direct)
View
Goto page 0, 1, Next